Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | MAP2K3 | P46734 | 1/20 | 0.46 |
| ▸ | MAP2K6 | P52564 | 1/20 | 0.46 |
| ▸ | BTK | Q06187 | 1/20 | 0.46 |
| ▸ | MAP3K19 | Q56UN5 | 1/20 | 0.46 |
| ▸ | NEK10 | Q6ZWH5 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | CASP7 | P55210 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzonaphthyridine SCHEMBL29600756 | 1.00 | GPR3 (1.00) | GPR3LMNAHTTKDM4EMAPT | |
| Benzonaphthyridine SCHEMBL51197 | 1.00 | GPR3 (1.00) | GPR3LMNAHTTKDM4EMAPT | |
| SCHEMBL4485428 | 0.93 | GPR3 (0.87) | GPR3LMNAHTTKDM4EMAPT | |
| Benzonaphthyridine SCHEMBL38660425 | 0.84 | GPR3 (0.70) | GPR3LMNAHTTKDM4ELCK | |
| SCHEMBL1179339 | 0.82 | GPR3 (0.67) | GPR3LMNAHTTKDM4ELCK | |
| SCHEMBL11195652 | 0.80 | GPR3 (0.64) | GPR3LMNAHTTKDM4EMAPT | |
| SCHEMBL7052017 | 0.80 | GPR3 (0.64) | GPR3LMNAHTTKDM4EMAPT | |
| SCHEMBL11203305 | 0.80 | GPR3 (0.64) | GPR3LMNAHTTKDM4EMAPT | |
| SCHEMBL5478388 | 0.80 | GPR3 (0.64) | GPR3LMNAKDM4EMAPTCYP1A2 | |
| SCHEMBL11198396 | 0.80 | GPR3 (0.64) | GPR3LMNAHTTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | disclosed |
| EP-4604992-A1 | VACCINE | GlaxoSmithKline Biologicals SA (BE) | 2025-08-27 | — | — | EP | disclosed |
| EP-3773549-B1 | COMBINATION OF QUINOLINE-4-CARBOXAMIDES AND BENZONAPHTHYRIDINE DERIVATIVES AS ANTIMALARIAL DRUG COMBINATION | MERCK PATENT GMBH (DE) | 2024-08-28 | — | — | EP | disclosed |
| WO-2024083873-A1 | VACCINE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | FCGR2A, FCGR3B, FCGR1A | GPR3 2363/4885LMNA 4284/4885HTT 2413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.